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Population with an increased risk of severe COVID-19 in Germany. 
Analyses from GEDA 2019/2020-EHIS
Abstract
Only a minority of people who test positive for COVID-19 develop a severe or critical form of the disease. Many of these 
have risk factors such as old age or pre-existing conditions and, therefore, are at the focus of protective measures. This 
article determines the number of people at risk in Germany and differentiates them according to age, sex, education, 
household type and federal state. The analyses presented here are based on data from the German Health Update (GEDA) 
2019/2020-EHIS, which was carried out as a nationwide cross-sectional telephone-based survey between April 2019 and 
October 2020. The definition of being at increased risk of severe COVID-19 is primarily based on a respondent’s age and 
the presence of pre-existing conditions. Around 36.5 million people in Germany are at an increased risk of developing 
severe COVID-19. Of these, 21.6 million belong to the high-risk group. An above-average number of people at risk live 
alone. The prevalence of an increased risk is higher among middle-aged men than among women of the same age, and 
significantly higher among people with a low level of education than among people with a high level of education. The 
highest proportion of people with an increased risk live in Saarland and in the eastern German federal states. When 
fighting the pandemic, it is important to account for the fact that more than half of the population aged 15 or over is at 
increased risk of severe illness. Moreover, the regional differences in risk burden should be taken into account when 
planning interventions.
  SARS-COV-2 · COVID-19 · PRE-EXISTING CONDITIONS · SECONDARY DISEASES · RISK FACTORS · HOSPITALISATION · MORTALITY
1. Introduction
SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona-
virus 2) and the Coronavirus Disease 2019 (COVID-19), 
have had a strong political and social impact on life in 
Germany in 2020. After a first wave of infections in spring 
and a sharp decline in new cases in summer, the numbers 
began to rise again significantly in October [1]. By the 
second half of November, the number of deaths clearly 
exceeded the level in spring [2]. The disease burden 
from death due to COVID-19 in 2020 is above the level 
that would normally be expected for lower respiratory infec-
tions during this period. Men account for almost two thirds 
of years of life lost to COVID-19, and people aged 70 for a 
share of more than 70% [2].
The vaccines that have been gradually approved since 
the end of 2020 are key to avoiding infections and severe 
illness. Since the number of vaccines available will be lim-
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tions or other risk factors. Of these, only a few condi-
tions, such as diabetes mellitus, organ transplants, heart 
failure, dementia, chronic kidney disease, Down’s syn-
drome or severe obesity (body mass index >40), are also 
associated with a strongly increased risk of hospitalisa-
tion or death [3]. Several others, such as psychiatric dis-
orders, cardiac arrhythmias, cardiovascular diseases, 
stroke, cancer, asthma and chronic obstructive pulmo-
nary disease (COPD) are linked to a moderately increased 
risk.
This article uses current data to identify the total num-
ber of people at increased risk of developing severe 
COVID-19 in Germany. In addition, it develops an approach 
with which to implement more in-depth analyses. Based 
on data from the German Health Update (GEDA 2019/2020-
EHIS), people aged 15 or above who have an increased risk 
of developing severe COVID-19 are further differentiated 
by age, sex, level of education, household type and federal 
state. Whereas the nationwide distribution of people with 
an increased risk can provide important information when 
allocating vaccines, sociodemographic factors are also use-
ful in terms of the likelihood of gaining access to particular 
population groups and on how best to design information 
campaigns.
2. Methodology
2.1 Study design, sample and weighting
GEDA 2019/2020-EHIS is a nationwide cross-sectional 
telephone-based survey of the resident population in Ger-
many aged 15 or above. The study collects data using a 
specially designed, fully structured computer assisted 
ited for the foreseeable future, access to vaccines needs to 
be regulated [3]. This is particularly important if vulnerable 
groups are to be protected. The priority groups for COVID-19 
vaccinations broadly fall into two categories: in addition to 
people in occupations deemed essential (e.g. nursing staff), 
who are often at high risk of infecting themselves and 
others, the focus is primarily placed on people with an 
increased risk of developing a severe form of the disease 
(vulnerable groups).
Data from the first COVID-19 wave demonstrates that 
only a minority of people who had a COVID-19 infection 
developed severe illness. While around 80% of the peo-
ple who tested positive developed mild cases, the rest 
suffered from complications such as pneumonia, and 
required inpatient or intensive care, or died. These are 
classified as severe or critical forms of the disease [4]. In 
order to reduce the burden of disease caused by COVID-19, 
therefore, it makes sense to prioritise people for the vac-
cine who are more likely to be affected by severe illness. 
The majority of these people have already reached an 
advanced age or have certain pre-existing conditions [4]. 
This means that the age distribution of people with an 
increased risk is particularly relevant when planning vac-
cination programmes.
The existing evidence can be used to clearly define risk 
factors associated with severe COVID-19 [3]. The data 
demonstrate that old age is the main risk factor for hos-
pitalisation and death, regardless of any pre-existing 
conditions. This evidence led the Standing Committee 
on Vaccination (STIKO) to recommend that older and 
very old people be prioritised for COVID-19 vaccination [3]. 
Moreover, many older people have pre-existing condi-
GEDA 2019/2020-EHIS
Fifth follow-up survey of the 
German Health Update
Data holder: Robert Koch Institute
Objectives: Provision of reliable information 
on the health status, health behaviour and 
health care of the population living in Ger-
many, with the possibility of European com-
parisons
Study design: Cross-sectional telephone 
survey
Population: German-speaking population 
aged 15 and older living in private house-
holds that can be reached via landline or 
mobile phone
Sampling: Random sample of landline and 
mobile telephone numbers (dual-frame 
method) from the ADM sampling system 
(Arbeitskreis Deutscher Markt- und Sozial-
forschungsinstitute e.V.)
Sample size: 23,001 respondents
Study period: April 2019 to September 2020
GEDA survey waves: 
  GEDA 2009
  GEDA 2010
  GEDA 2012
  GEDA 2014/2015-EHIS
  GEDA 2019/2020-EHIS
Further information in German is available at
www.geda-studie.de
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Data on the 12-month prevalence of pre-existing conditions 
was gathered using the question: ‘Have you had any of the 
following illnesses or complaints in the last 12 months?’ 
(For a list of the conditions concerned, see Chapter 2.3).
Body weight and body mass index
Body weight and height are based on information provid-
ed by the respondents. Data on height was collected using 
the question: ‘How tall are you if you are not wearing 
shoes?’ and was recorded in centimetres. Data on body 
weight was collected with the question: ‘How much do you 
weigh if you are not wearing clothes or shoes? Please enter 
your body weight in kilogrammes’. Body Mass Index (BMI) 
is calculated using the ratio of body weight to body height 
squared (kg/m2).
Need for help
People aged 55 or above were asked whether they needed 
help with activities of daily living (ADL) [12] or with instru-
mental activities of daily living (iADL) [13]. ADLs include 
eating and drinking, getting up from or sitting down on 
a bed or chair, dressing/undressing, using the toilet, or 
bathing and showering. iADLs include meal preparation, 
making phone calls, shopping, taking medication, light 
or occasionally heavy housework, and administrative 
tasks. Respondents who said they needed help with at 
least two of these activities were categorised as needing 
help.
telephone interview (CATI). The GEDA study has been car-
ried out, at intervals of several years, by the Robert Koch 
Institute (RKI) on behalf of the German Federal Ministry 
of Health since 2008, and is part of the health monitoring 
system at the RKI [5, 6]. The European Health Interview 
Survey (EHIS) was supplemented and fully integrated into 
the study [7]. The current GEDA wave is based on a ran-
dom sample of landline and mobile phone numbers derived 
from a telephone sample collected by ADM (Arbeitskreis 
Deutscher Markt- und Sozialforschungsinstitute e.V.) [8, 9]. 
The sample covers the population aged 15 or above living 
in private households and residing in Germany at the time 
of data collection [8, 10].
The interviews were undertaken between April 2019 
and October 2020 by an external market and social 
research institute under the continuous supervision of 
the RKI. A total of 23,001 (12,111 female, 10,890 male) 
people who took part in the GEDA 2019/2020-EHIS study 
provided complete interviews. The response rate was cal-
culated using the standards drawn up by the American 
Association for Public Opinion Research (AAPOR) and 
amounted to 21.6% (RR3) [11]. Design weighting was ini-
tially carried out for the different selection probabilities 
(mobile and landline networks) using a standard calcula-
tion method as part of the dual-frame design. The sample 
was then adjusted to ensure that it reflected official pop-
ulation figures in terms of age, sex, federal state, district 
type (as of 31 December 2019) and education (in line with 
the pattern identified in the 2017 microcensus using the 
International Standard Classification of Education – ISCED 
classification) [8, 10].
 
Older age and certain  
pre-existing conditions 
increase a person’s risk  
of severe COVID-19.
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Education levels are based on the CASMIN system (Com-
parative Analyses of Social Mobility in Industrial Nations) 
and used as an indicator of social status. Academic and 
vocational qualifications are used to distinguish between 
three groups: low, medium and high levels of education [14].
The respondents are also categorised by household type: 
people living alone are distinguished from couples without 
children, families with children and people living together 
in a different or unknown household type. Families also 
include single parents living with adult children in the 
household. Other household types include individuals liv-
ing with people who are not partners or family members.
2.3 Definition of risk
Two types of risk groups are defined: the first includes every-
one who is at increased risk of developing severe COVID-19; 
the second includes everyone within this group who has a 
strongly increased risk of developing severe disease. The 
definition of the two risk groups was based on findings 
derived from a systematic literature analysis carried out by 
the RKI as an umbrella review. The analysis was undertak-
en as part of the process used by the Standing Committee 
on Vaccination at the RKI to draw up its recommendations 
on vaccination priority [3, 15]. Only those conditions or risk 
factors could be taken into account by the applied risk defi-
nition, that were actually surveyed in GEDA 2019/2020-
EHIS. In order to compensate to some extent for unmea-
sured morbidity, people in need of additional help are also 
included in the definition. The risk groups were defined 
using the criteria set out in Table 1.
An increased risk (risk group) was assumed for individuals:
  aged 65 or above
or
  with pre-existing conditions or risk factors1 that the literature 
analysis showed to be associated with a:  
relative risk >1 of hospitalisation [a] or death [b] [3]
(i) High blood pressure [a]
(ii) Coronary heart disease/angina pectoris [b] 2
(iii) Heart attack or chronic complications [b] 2
(iv) Stroke or chronic complications [a] 3 
(v) Diabetes mellitus [a, b]
(vi) Bronchial asthma [a]
(vii) Chronic bronchitis [a, b] 4
(viii) Liver cirrhosis [a, b] 5
(ix) Chronic kidney problems [a, b]
(x)  Obesity (Body Mass Index ≥ 30) [a, b]
or
  with an additional need for help 
People were defined as belonging to a subgroup with a 
strongly increased risk (high-risk group) if they were:
  aged 65 or above
or
  had at least one of the pre-existing conditions or risk fac-
tors that the literature analysis showed to be associated 
with a: 
relative risk >2 of hospitalisation or death [3]: diabetes  
mellitus, chronic kidney problems, obesity (BMI ≥ 40)6
BMI=Body Mass Index
1 The risk factors of cancer, dementia, rheumatological disease, organ trans-
plantation, autoimmune disease, a compromised immune system and HIV 
infection, which were determined from the literature analysis, were not con-
sidered in GEDA 2019/2020-EHIS.
2 Coronary artery disease was examined as a risk factor in the underlying  
literature study.
3 Cerebrovascular disease or apoplexy was investigated as a risk factor in the 
underlying literature study.
4 Chronic obstructive pulmonary disease (COPD) was examined as a risk factor 
in the underlying literature study.
5 Chronic liver disease was investigated as a risk factor in the underlying liter-
ature study.
6 BMI is associated with a continuous increase in risk. The literature review 
found that people with a BMI ≥ 40 should be placed in the high-risk group 
(result not shown in [3]).
Table 1 
Definition of an increased or strongly increased 
risk of severe COVID-19 based on data from 
GEDA 2019/2020-EHIS 
Source: Own table
About 36.5 million people in 
Germany have an increased 
risk of severe COVID-19;  
21.6 million of these belong 
to the high-risk group.
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individuals are women and 48.9% are men. 30.6% of the 
population aged 15 or over has a strongly increased risk of 
developing severe COVID-19. This corresponds to 21.6 mil-
lion individuals being at high risk in Germany. Of these, 
53.7% are women and 48.3% are men.
The risk of developing severe COVID-19 increases steadi-
 ly with age, beginning at a young age. The proportion of 
people at increased risk is 20.5% of 20- to 24-year-olds, 
40.2% of 45- to 49-year-olds and 60.9% of 60- to 64-year-
olds. In contrast, the proportion of people in the high-risk 
group initially remains at a low level among younger and 
middle-aged people. Up to the fifth decade of life, less than 
one-in-ten people belong to the high-risk group. In fact, 
only 17.7% of 60- to 64-year-olds are at high risk. Therefore, 
most people are at a high risk due to their advanced age 
(Figure 1). Nonetheless, many middle-aged people also are 
at risk of developing severe COVID-19. 15.5 million people 
in Germany under the age of 60 have an increased risk and 
3.0 million have a strongly increased risk of developing 
severe COVID-19 (Annex Table 1).
The data demonstrate a statistically significantly higher 
proportion of men in the group with an increased risk of 
severe COVID-19. This particularly applies to middle-aged 
men. The difference between men and women is most pro-
nounced between the ages of 45 and 49, with 35.3% of 
women and 45.0% of men in this age group deemed to be 
at an increased risk.
3.2 Risk groups by education and household type
Clear differences were identified by education level. Where-
as 69.8% of people with a low level of education in 
2.4 Sensitivity analysis
A sensitivity analysis was undertaken with data from the 
previous GEDA 2014/2015-EHIS study [16]. This allowed 
to widen the definition by including pre-existing conditions 
that had been examined in 2014/2015 but not in 2019/2020. 
An analysis was undertaken using heart failure and cancer 
as examples to determine how the size of the risk group 
in Germany might change if people with these conditions 
were included in the group considered to be at risk.
The diseases were selected because they were associated 
with a relative risk >1 of hospitalisation (heart failure) or death 
(heart failure, cancer) according to literature analysis [3].
2.5 Statistical analysis
Weighted proportions and extrapolated population num-
bers for people with an increased or strongly increased risk 
for severe COVID-19 are depicted by age, sex, education, 
household type and federal state. A statistically significant 
difference between subpopulations is assumed where p-val-
ues are less than 0.05 (using a Pearson test for survey sam-
ples). All analyses were performed using StataSE 15.1 (Stata 
Corp., College Station, TX, USA, 2017).
3. Results 
3.1 Groups at risk of developing severe COVID-19
The results show that 51.9% of the population in Germany 
aged 15 or over is at increased risk of developing severe 
COVID-19. Extrapolated to the German population, this 
corresponds to about 36.5 million people. 51.1% of these 
70% of people with a low 
level of education and 40% 
of people with a high level  
of education are at an 
increased risk of severe 
COVID-19.
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total, around 16.8 million people who live alone have an 
increased risk of developing severe COVID-19. Neverthe-
less, the proportion of the risk group living with other fam-
ily members is still 17.7%. As such, around 5.7 million peo-
ple with an increased risk of developing severe COVID-19 
are potentially being exposed to an even higher risk of infec-
tion due to the greater level of contact that they have with 
other people in multi-generational households (Table 2).
3.3 Regional differences in the risk of developing severe 
COVID-19
The analysis by federal state demonstrates that the popu-
lation at risk is distributed unequally throughout Germany. 
Germany belong to the risk group, this applies to 45.1% of 
people with a medium and 40.9% of people with a high 
level of education. At 49.2%, the proportion of people in 
the high-risk group is more than 25 percentage points high-
er among people with a low level of education than among 
people with a medium (21.9%) or high level of education 
(23.9%) (Figure 2).
The respondents’ household type varies significantly by 
risk status. Less than one-third of people who are not cat-
egorised as at risk live alone, with almost half of these indi-
viduals living with a partner or with other family members. 
The proportion of people living alone rises considerably 
with increasing risk: 45.9% of people from the risk group 













Age group (years)Risk group High-risk group
Figure 1 
Population with an increased risk of severe 
COVID-19; share of risk group 
including the high-risk group by age 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS
45.9% of people in the risk 
group and 53.4% of people  
in the high-risk group  
live alone.
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numbers of people at increased risk slightly differ from 
the figures that would be expected due to the size of the 
population. That is, based on the proportion of the Ger-
man population aged 15 and older living in Saxony-Anhalt 
(2.7%), 0.98 million people would be expected to be at 
an increased risk of developing severe COVID-19. How-
ever, the estimates calculated using data from the GEDA 
2019/2020-EHIS study demonstrate that around 1.17 mil-
lion people are at risk in Saxony-Anhalt. Similarly, with 
15.8% of the German population living in Bavaria, 5.74 
million people would be expected to be at increased risk; 
the analysis found the figure to be closer to 5.46 million 
(Annex Table 2).
3.4 Sensitivity analysis
If in GEDA 2014/2015-EHIS the same definition of 
increased risk of developing severe COVID-19 is applied 
plus pre-existing conditions such as heart failure and can-
cer, the estimated population at risk would increase by 
around 465,000 people. As such, if the analyses present-
ed here have underestimated the size of the risk group, it 
will have done so by probably less than about one million 
people
The proportion of people in the high-risk group is highest 
in Saxony-Anhalt. The high-risk group is proportionally 
most strongly represented in Saxony and Thuringia. The 
share is lowest in Bavaria, Baden-Württemberg and the 
city states of Berlin and Hamburg. Generally, the propor-
tions are higher in the eastern federal states than in the 
western federal states and are particularly low in southern 
Germany (Figure 3, Annex Table 2). These differences in 
















Risk group High-risk group education
Figure 2 
Population at increased risk of severe 
COVID-19; share of risk group 
including the high-risk group by education 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS
Table 2 
Population in Germany by household type 
and risk of developing severe COVID-19 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS













Living alone 10.3 30.3 16.8 45.9 11.5 53.5 
Couple without children 6.2 18.3 11.2 30.6 7.5 34.8 
Family with children (including adult children) 9.9 29.1 5.7 17.7 1.6 7.3 
Different household type/unknown 7.6 22.3 2.8 7.8 1.0 4.5 
Total 33.0 100 36.5 100 21.6 100
The largest proportion of 
people with a high risk of 
severe COVID-19 live in 
eastern Germany and  
Saarland, both of which are 
rather sparsely populated 
areas.
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definition [17]. The Central Institute for Statutory Health 
Insurance in Germany (Zi) identified a significantly lower 
prevalence among people under 60 than the results pre-
sented here [18]. However, neither of these studies includ-
ed obesity as an important risk factor. Furthermore, old age 
is now accepted as the main risk factor for developing 
severe COVID-19 [3], and it was not included in these esti-
mates as a population-related parameter. As such, the high-
er number of people identified as at risk in Germany by this 
study is plausible. Moreover, a European comparison found 
4. Discussion
In Germany, 36.5 million people – more than half of the 
population aged 15 or above – are at risk of developing 
severe COVID-19. Almost one-third – 21.6 million people 
– is at a strongly increased risk. Only a few attempts have 
previously been made to quantify the size of these risk 
groups in Germany. An extrapolation based on claims 
data from people with AOK health insurance found that 
21.6 million people were at risk – albeit using a different 
Figure 3 
Population groups in Germany at risk of 
severe COVID-19 by federal state 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS
        <50%
50%–<53%
53%–<56%
       ≥56%
        <30%
30%–<33%
33%–<36%
       ≥36%
Risk group High-risk group
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ciated biases to some extent. The results presented here 
assume that the measures put in place to contain the 
COVID-19 pandemic during the study period did not lead 
to any form of systematic bias. However, a temporary 
change in the willingness of individual population groups 
to participate in telephone-based surveys cannot be com-
pletely ruled out, even though initial analyses that have 
compared 2019 and 2020 suggest that this is not the case 
[8, 10]. Some important pre-existing conditions that are 
associated with a risk of developing severe COVID-19, such 
as heart failure, dementia or cancer, could not be included 
in the definition used in this article. However, the sensitiv-
ity analyses demonstrated that this limitation will have had 
little impact on the size of the risk groups. 
The analyses presented here, therefore, are plausible. 
They describe the population in need of special protection, 
which should be addressed with targeted measures as a 
priority, if necessary. In contrast to previous analyses based 
on claims data, GEDA 2019/2020-EHIS also enables social 
determinants of an increased risk to be clearly identified. 
Future research should involve in-depth analyses that focus 
more closely on combinations of social risk factors, since 
sex, age, education and household composition do not 
independently determine a person’s risk of developing 
severe COVID-19. It is clear, however, that the risk of devel-
oping severe COVID-19 is distributed unequally across 
society. A lower level of education is associated not only 
with a higher risk of developing severe COVID-19, but 
also with a more frequent tendency to be sceptical about 
SARS-CoV-2 vaccinations, as a survey by the German Insti-
tute for Economic Research shows [31]. Target group-spe-
cific approaches to contain the COVID-19 pandemic could 
that Germany had one of the highest population-based 
risks for a severe form of COVID-19 [19].
The fact that slightly more women than men appear to 
be at risk can be attributed to their higher life expectancy. 
The prevalence of an increased risk of developing severe 
COVID-19 is actually higher among middle-aged men than 
among women of the same age. These differences between 
women and men, among other factors, are thought to 
explain the higher level of COVID-19 mortality among men 
[20]. Men become seriously ill with COVID-19 more fre-
quently at a younger age and are more likely to die than 
women before their sixth decade of life [21, 22]. As such, 
the disease burden, calculated in years of life lost, is sig-
nificantly higher among men than women [2].
The differences in the distribution of increased risk of 
developing severe COVID-19 by education also reflect the 
literature on socioeconomic health inequalities in Germany 
[23, 24]. In the case of cumulative risks, as in the present 
definition, such inequalities are particularly pronounced. 
The international literature also demonstrates that people 
with a low socioeconomic status are at higher risk of severe 
COVID-19 [25]. Regional differences in health are also well 
documented for Germany and show, for example, similar 
patterns for diabetes, high blood pressure, asthma and 
COPD, with higher prevalence rates in the eastern German 
federal states and Saarland [26–29].
Telephone-based surveys are often associated with the 
limitation of lower response rates compared with face-to-
face surveys. However, this does not necessarily lead to a 
higher level of non-response bias [30]. In addition, sample 
weighting compensates for differences between the sam-
ple and the general population, and, therefore, for the asso-
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The German version of the article is available at: 
www.rki.de/journalhealthmonitoring
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therefore be suitable for tailoring COVID-19 interventions 
more accurately. Furthermore, the differences in the dis-
ease burden of COVID-19 by sex indicate that men with an 
increased risk even at a younger age also constitute a spe-
cial target group and should be particularly encouraged 
to take up vaccination. The different risk burden found in 
different regions could also be relevant when allocating 
vaccine. It is also important to bear in mind that 16.8 mil-
lion people at risk live alone. Among these individuals are 
likely to be many of the 3.3 million people in need of long-
term care [32] and in general many elderly community- 
dwelling people. As such, a proportion of these people 
could possibly be reached more successfully using outreach 
measures than opting for invitation-based procedures.
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Risk group High-risk group
Age group 
15 to ...
% 95% CI Number 
(millions)
95% CI % 95% CI Number 
(millions)
95% CI
<50 years 27.1 25.7–28.4 9.1 8.6–9.7 4.8 4.1–5.6 1.6 1.4 –1.9
<60 years 32.9 31.7–34.1 15.5 14.8 –16.1 6.4 5.8–7.1 3.0 2.7–3.3
<70 years 41.2 40.2– 42.3 23.8 23.1–24.5 15.3 14.5 –16.0 8.8 8.4 –9.2
Total (≥15 years) 51.9 50.9–52.9 36.5 35.7–37.4 30.6 29.7–31.5 21.6 20.9–22.2
CI=confidence interval
Risk group High-risk group 
Federal state % 95% CI Number 
(millions)
95% CI % 95% CI Number 
(millions)
95% CI
Baden-Württemberg 49.0 46.3–51.7 4.61 4.27– 4.95 28.4 26.2–30.9 2.68 2.43–2.93
Bavaria 49.0 46.5–51.5 5.46 5.07–5.85 28.4 26.2–30.8 3.17 2.86–3.47
Berlin 48.8 45.6–52.1 1.52 1.39–1.65 28.4 25.8–31.1 0.88 0.79–0.97
Brandenburg 59.3 54.1–64.2 1.27 1.10–1.44 34.6 30.0–39.5 0.74 0.62–0.86
Bremen 54.1 42.1–65.6 0.30 0.21–0.39 31.7 22.4– 42.8 0.18 0.11–0.24
Hamburg 49.7 44.0–55.3 0.76 0.64–0.88 28.7 23.9–34.0 0.44 0.35–0.53
Hessen 50.9 47.2–54.6 2.70 2.44–2.96 30.3 27.2–33.5 1.60 1.41–1.79
Mecklenburg-Western Pomerania 59.8 52.8–66.5 0.81 0.66–0.96 35.3 29.2– 41.9 0.48 0.38–0.58
Lower Saxony 53.1 49.8–56.4 3.58 3.26–3.90 32.2 29.3–35.4 2.18 1.93–2.42
Nordrhein-Westfalen 52.2 50.0–54.5 7.84 7.38–8.30 30.0 28.1–32.0 4.51 4.17– 4.85
Rhineland-Palatinate 51.7 47.3–56.2 1.80 1.59–2.02 31.0 27.2–35.0 1.08 0.93–1.24
Saarland 58.5 55.0–61.9 0.50 0.46–0.54 35.2 32.2–38.3 0.30 0.27–0.33
Saxony 53.8 49.2–58.4 1.85 1.62–2.07 37.0 32.8– 41.4 1.27 1.09–1.45
Saxony-Anhalt 62.3 56.2–67.9 1.17 1.00–1.35 36.7 31.2– 42.4 0.69 0.56–0.82
Schleswig-Holstein 55.1 50.3–59.8 1.37 1.19–1.55 33.5 29.4–38.0 0.83 0.71–0.96
Thuringia 59.4 53.2–65.4 1.09 0.91–1.26 37.0 31.2– 43.2 0.68 0.54–0.82
CI=confidence interval
Annex Table 1 
Proportion and extrapolated number of 
people with an increased and high risk 
of severe COVID-19 by age 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS
Annex Table 2 
Proportion and extrapolated number of 
people with an increased and high risk 
of severe COVID-19 by federal state 
(n=11,880 women, n=10,816 men) 
Source: GEDA 2019/2020-EHIS
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